Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations.
about
Genes involved in the metabolism of poly-unsaturated fatty-acids (PUFA) and risk for Crohn's disease in children & young adults.NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease.Ulcerative colitis in a Nigerian girl: a case report.Transitional care in inflammatory bowel disease.Measuring quality of life in pediatric patients with inflammatory bowel disease: psychometric and clinical characteristics.Ulcerative colitis in infancyBiologics in paediatric Crohn's disease.Interpretability of the PedsQL™ Gastrointestinal Symptoms Scales and Gastrointestinal Worry Scales in Pediatric Patients With Functional and Organic Gastrointestinal Diseases.Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel diseaseCorrelation of MMP-3 and MMP-9 with Crohn's disease activity in childrenNew patients: should children be treated differently?The natural history of ulcerative colitis in a pediatric population: a follow-up population-based cohort study.The natural course of inflammatory bowel disease-indeterminate from childhood to adulthood: within a 25 year period.Adolescents' Lived Experiences While Hospitalized After Surgery for Ulcerative Colitis.Specific considerations in the treatment of pediatric inflammatory bowel disease.Health supervision in the management of children and adolescents with IBD: NASPGHAN recommendations.Matrix metalloproteinase-9: its interplay with angiogenic factors in inflammatory bowel diseasesSerologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.Genetics of childhood-onset inflammatory bowel disease.Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.Transition of the patient with IBD from pediatric to adult care-an assessment of current evidence.Very early-onset inflammatory bowel disease: gaining insight through focused discovery.Pediatric inflammatory bowel disease: imaging issues with targeted solutions.Particularities of Crohn's disease in pediatric patients: current status and perspectives regarding imaging modalities.Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nursesPsychological consultation in a paediatric setting: A qualitative analysis of staff experiences of a psychosocial forum.An Overview of Inflammatory Bowel Disease: General Consideration and Genetic Screening Approach in Diagnosis of Early Onset Subsets.Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000-2004: A prospective population-based study.Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls.Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab.Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study.Timing, frequency and type of physician-diagnosed infections in childhood and risk for Crohn's disease in children and young adults.Transition experience of young adults with inflammatory bowel diseases (IBD): a mixed methods study.Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease.Reduced muscle mass and bone size in pediatric patients with inflammatory bowel disease.Coping is excellent in Swiss Children with inflammatory bowel disease: results from the Swiss IBD cohort study.Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: a randomized placebo-controlled trial.Investigation of associations between the pregnane-X receptor gene (NR1I2) and Crohn's disease in Canadian children using a gene-wide haplotype-based approach.
P2860
Q33781057-AE059367-076C-4499-B5CA-3AA96AF2ACEEQ33782065-902E8D89-576F-48E4-B62E-DA61340D3AC2Q34439031-97C576F9-259E-4407-B605-EC57AF76C5F0Q34571165-9BA5CD73-16CE-4153-9163-E0CA63636637Q34727793-F11BDAA2-F6A3-4814-A369-8A72826BCB50Q35564346-298A07FE-A4F6-40D9-8CF9-1AC19D5238B3Q35579308-FCF7CF65-2DBD-4F65-93B6-03272594FB9AQ35749754-62C81159-42DE-4E29-95DF-073AA7ABC31FQ35760586-FFE36912-D7A6-4BD8-84B1-BDE66BC0B7C7Q35767203-80C106D0-462D-479E-B036-CBAF9DEC675AQ36440544-26AD1D67-6347-416D-B9F7-8F3BB8B08649Q36972172-B3FB85E9-E7DE-413D-8D51-E19C60FA32AAQ37053304-7C491294-5755-4C92-B009-26B2EA1E4DD2Q37143404-CF298902-B0ED-4CAE-AF10-BA8879F69947Q37345918-EAF9F877-7102-4F3C-A0AD-591FCE2EC038Q37492482-A0C3F49E-5B5D-4154-A193-7AFEDB7349E3Q37706103-4C14DA46-9AF8-419E-908B-4827909E8679Q37777013-3044DBD5-D2E5-4DC6-81F6-80DDE8E2DBF1Q37788639-A6B9BFF2-B58D-4CE7-950A-97D9DE0AE48BQ38035199-D9C02B9C-10C7-4813-A9AA-A9FF7A500974Q38213338-015A8B7E-35E3-4889-BAE0-DA6B80DB3899Q38430977-5B3EC246-26E7-41FD-8621-BFEDB530E67FQ38446635-61449CDF-AC17-4517-ACAB-DE92F2DCF704Q38588082-69A25471-A22A-4485-8A23-0EB2E58F023EQ38614996-3CC1C7C7-B884-405D-9DCF-D3DBE91821FFQ39213890-29326589-4A44-4289-B27C-214BE840D9D6Q39389508-125A557F-3C9D-4A22-ADC1-B743E96ECED6Q39752914-2CA5AAEB-1195-46C8-AFD3-DD482BD8FA43Q40122523-D1B49873-EFA1-4BBE-8D21-0E572FE29292Q40265182-5E98E668-168D-4B20-BCCE-D164B62E3C1AQ42129954-7924EA93-AFE3-4D56-9788-A6195732FB9EQ42775426-144133B2-C894-40CF-940C-CE450E53538AQ43420488-F0BFA3CD-E813-49B3-BA36-546141266EB8Q43569418-6ED05448-9094-452C-BA68-860117C0E5DBQ44117651-E1EC5708-0B5B-402B-8ECC-039E34891489Q44389620-FB86A1C4-101B-4F00-934D-99EEC2C235DDQ45088731-D9559E3F-DFEF-4152-999C-7B0ECB279318Q45341422-7359D3E6-6CC7-47A9-8C91-1093A3F56290Q46115976-722D6FEE-1A15-4B6E-8FCD-5EDD470321FAQ46669955-240FA79E-7F6E-4149-9A70-17D58628FA19
P2860
Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inflammatory bowel diseases in ...... d psychosocial considerations.
@ast
Inflammatory bowel diseases in ...... d psychosocial considerations.
@en
type
label
Inflammatory bowel diseases in ...... d psychosocial considerations.
@ast
Inflammatory bowel diseases in ...... d psychosocial considerations.
@en
prefLabel
Inflammatory bowel diseases in ...... d psychosocial considerations.
@ast
Inflammatory bowel diseases in ...... d psychosocial considerations.
@en
P1433
P1476
Inflammatory bowel diseases in ...... d psychosocial considerations.
@en
P2093
George D Ferry
Sandra C Kim
P304
P356
10.1053/J.GASTRO.2004.03.022
P407
P577
2004-05-01T00:00:00Z